We are live on ! Find out more
TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
+6.48%
1 Year Est. Return
+18.15%
3 Year Est. Return
+62.51%
5 Year Est. Return
+140.53%
10 Year Est. Return
+502.91%
AUM
$2.13B
AUM Growth
+$1.04B
Cap. Flow
+$940M
Cap. Flow %
44.08%
Top 10 Hldgs %
46.5%
Holding
110
New
45
Increased
37
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$98.6M
2
GILD icon
Gilead Sciences
GILD
+$96.5M
3
PFE icon
Pfizer
PFE
+$46.4M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.9M
5
ABBV icon
AbbVie
ABBV
+$26.7M

Top Sells

Rank Stock Value
1
FRX
FOREST LABORATORIES INC
FRX
+$10.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.11M
3
AEGR
Aegerion Pharmaceuticals
AEGR
+$1K

Sector Composition

Rank Sector Weight
1 Healthcare 81.82%
2 Real Estate 2.39%
3 Financials 1.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
101
Agios Pharmaceuticals
AGIO
$1.95B
$2.15M 0.1%
+35,000
New +$1.51M
LITS
102
Lite Strategy Inc
LITS
$33.6M
$1.68M 0.08%
12,196
– –
ACOR
103
CALL
DELISTED
Acorda Therapeutics
ACOR
$1.61M 0.08%
+395
New +$1.48M
MGNX icon
104
MacroGenics
MGNX
$240M
$666K 0.03%
31,857
– –
ACHV icon
105
Achieve Life Sciences
ACHV
$647M
$302K 0.01%
51
– –
SAGE
106
DELISTED
Sage Therapeutics
SAGE
$158K 0.01%
+5,000
New +$145K
AEGR
107
DELISTED
Aegerion Pharmaceuticals
AEGR
– –
-20
Closed -$1K
FRX
108
DELISTED
FOREST LABORATORIES INC
FRX
– –
-109,875
Closed -$10.9M
1 2 3 4
5

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
BWM
BerganKDV Wealth Management Bloomington, Minnesota $1,000M AUM 9.95% 1-Year Est. Return

Tekla Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Tekla Capital Management held 110 positions worth $2.13B, up 96% from $1.09B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Tekla Capital Management deployed $940M of net new capital in Q3 2014, opening 45 new positions and adding to 37 existing holdings. Its largest new stake was Johnson & Johnson: 327,212 shares worth $34.9M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 89% a quarter earlier, followed by Real Estate and Financials.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $2.11M trimmed.

  • Tekla Capital Management's largest Q3 2014 buy was Johnson & Johnson: 327,212 shares worth $34.9M.
  • Tekla Capital Management added most to Celgene Corp in Q3 2014, an estimated $98.6M increase.
  • Tekla Capital Management's biggest Q3 2014 reduction was Regeneron Pharmaceuticals, cutting an estimated $2.11M.
  • Tekla Capital Management fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $10.9M.
  • Tekla Capital Management's ten largest holdings make up 47% of its $2.13B portfolio in Q3 2014.
  • Tekla Capital Management opened 45 new positions and closed 2 in Q3 2014.
  • Tekla Capital Management's portfolio value rose 96% quarter-over-quarter to $2.13B.

Based on Tekla Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.